Effect of Autologous Platelet Rich Fibrin on Post-Operative Complications and Healing Following the Extraction

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

August 30, 2022

Conditions
Pain, PostoperativePost Operative SwellingTrismusSoft Tissue Healing
Interventions
PROCEDURE

application of PRF

PRF will be randomly administered into one group of patients undergoing any extractions group A (Right after the extraction) Group B will be a control group in which extraction sockets will be left to heal with the natural blood clot. Consenting patients will be assigned into groups randomly and not informed which group they were placed into. The PRF will be administered obtained from a tube of 10 ml blood and no material will be placed in the control group. The progress of healing and post-operative complications will be tracked over a period of 7 days with patients being called for follow-up on days 3, 5 and 7

PROCEDURE

application of conventional surgicel

it will be a control group in which extraction sockets will be left to heal with the natural blood clot.

Trial Locations (1)

75400

Department of Oral and Maxillofacial Surgery, Dow University of Health Sciences, Karachi

All Listed Sponsors
lead

Dow University of Health Sciences

OTHER

NCT06609967 - Effect of Autologous Platelet Rich Fibrin on Post-Operative Complications and Healing Following the Extraction | Biotech Hunter | Biotech Hunter